Free Trial
ASX:API

Australian Pharmaceutical Industries (API) Stock Price, News & Analysis

Australian Pharmaceutical Industries logo

About Australian Pharmaceutical Industries Stock (ASX:API)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
453,647 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
2.29%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive API Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Australian Pharmaceutical Industries and its competitors with MarketBeat's FREE daily newsletter.

API Stock News Headlines

China just unlocked Nvidia’s AI chips—what that means for you
Tired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system tracks breaking AI news and shows when to trade.📈 AI-backed. Beginner-friendly. Results proven.
Elon Musk's xAI launched its own API
See More Headlines

API Stock Analysis - Frequently Asked Questions

Australian Pharmaceutical Industries Limited (ASX:API) issued its quarterly earnings results on Wednesday, April, 17th. The company reported $0.05 EPS for the quarter, missing analysts' consensus estimates of $0.05 by $0.00.

Based on aggregate information from My MarketBeat watchlists, some other companies that Australian Pharmaceutical Industries investors own include Capricorn Metals (CMM), Allied Gaming & Entertainment (AGAE), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO), Berkeley Energia (BKY), Global X Cloud Computing ETF (CLOU) and Downer EDI (DOW).

Company Calendar

Last Earnings
4/17/2019
Today
8/02/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
Medical Equipment Wholesale
Sub-Industry
Computer Software
Current Symbol
ASX:API
CIK
N/A
Fax
N/A
Employees
1,310
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
1.28
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
71.32
Current Ratio
1.20
Quick Ratio
0.77

Sales & Book Value

Annual Sales
A$4.00 billion
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
8.26
Book Value
A$0.89 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
492,656,000
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (ASX:API) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners